IDO1 and cancer: A review by Heng et al. [119] identified that increased expression of indoleamine-2,3-dioxygenase 1 (IDO1), an enzyme involved in the synthesis of kynurenine from tryptophan, is positively correlated with poorer cancer prognosis across different cancers, including lung cancer.